CD79A and COVID-19: The finding of IgA antibodies to RBD in the nasal cavity, bronchi, and gastrointestinal tract of mice after intranasal immunization with RBD displayed on the surface of live Lactobacillus plantarum illustrates the potential of this platform for developing a nasal COVID-19 vaccine [54].